Point-of-Care Testing Devices
The U.S. point-of-care testing device market is growing with rising demand for rapid diagnostics, decentralized testing, and faster clinical decision-making across healthcare settings. Our research provides actionable insights into market size, technology adoption, competitive developments, and investment opportunities across molecular diagnostics, immunoassays, glucose testing, and infectious disease testing devices.
The U.S. Point-of-Care Testing Devices Market is projected to expand from USD 20.85 billion in 2026 to USD 34.62 billion by 2032 at an 8.84% CAGR. Expansion is propelled by acute emergency triage demands, urgent care network scaling, continuous biosensing adoption, and value-based healthcare models prioritizing decentralized testing to compress turnaround times, reduce hospital boarding, and improve outcomes.
Read Report Details